Biome Australia Ltd · ASX:BIO
Biome Australia — Investor Presentation (October 2022)
28 slides from Biome Australia's investor presentation, Oct 4, 2022
Slide 1: Biome Australia Limited FY22 Presentation
Biome Australia Limited Commercial in confidence FY22 Presentation Blair Norfolk, CEO e: blair@activated.co BIOME AUSTRALIA.COM Douglas Loh, CFO e: douglas@activated.co
Slide 2: Disclaimer
Disclaimer This presentation and the information contained within it (the Past performance information included in this presentation The recipient must, and agrees with the Company that “information”) has been prepared solely for the use and is provided for illustrative purposes only, should not be
Slide 3: Our mission
Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Commercial in confidence PG.3
Slide 4: About Biome Australia
About Biome Australia Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven condition-specific probiotic products fueled by novel clinical research programs to cement and extend the evidence base of its probiotic products
Slide 5: Investment and Business Highlights
01 PAGE 5 Practitioner-only probiotics Investment and Business Highlights ACTIVATEDPROBIOTICS.COM.AU Commercial in confidence PG.5
Slide 6: FY22 Key Stats - Successes
FY22 Key Stats - Successes PAGE 6 Practitioner-only probiotics FY22 Key Performance Indicators FY22 $4.12m up 78% vs FY21 Gross margin increased to 58% ACTIVATEDPROBIOTICS.COM.AU Annualised revenue of $5.56m (Q4 FY22) Pre-tax loss ($4.5m) improved by $840k or 16% Cash balance $5.5m FY22 operating ca
Slide 7: FY22 Business Highlights
FY22 Business Highlights Widespread distribution FY22 Key Performance Indicators Over 3,000 distribution points in Australia, with Signed Priceline Pharmacy Distribution sales of Activated Probiotics also in the UK & Agreement – 370 high volume service based NZ – 50% increase since November 30 IPO p
Slide 8: FY23 Q1 and Sales Revenue Forecast
FY23 Q1 and Sales Revenue Forecast PAGE 8 Practitioner-only probiotics Q1 FY23 Key Performance Indicators Q1 Sales Revenue $1.56m up 70% vs PCP Gross margin maintained at 58% ACTIVATEDPROBIOTICS.COM.AU Forecast Sales Revenue $7m for FY23 Priceline Pharmacy national launch Commercial in confidence PG
Slide 9: Quarterly Sales Growth
Quarterly Sales Growth Commercial in confidence PG.9
Slide 10: Sales Growth
Sales Growth Commercial in confidence PG.10
Slide 11: Range
02 Range Activated Probiotics Commercial in confidence PG.11 ACTIVATEDPROBIOTICS.COM.AU Practitioner-only probiotics PAGE 11
Slide 12: Activated Probiotics
Biome DailyTM Biome IBSTM Activated Probiotics DIGESTIVE HEALTH To help enhance immune To relieve the symptoms of system function and promote medically diagnosed IBS healthy digestion Practitioners & Pharmacies CONSUMER BENEFITS Biome Her Biome Prenatal+TM To help maintain a healthy To support a hea
Slide 13: Clinical Research
03 Clinical Research Commercial in confidence PG.13 ACTIVATEDPROBIOTICS.COM.AU Practitioner-only probiotics PAGE 13
Slide 14: Clinical pipeline - Indication overview
Clinical pipeline - Indication overview ● Three ongoing clinical trials and further research opportunities in discussion BIOME LIFT BIOME KIDS BIOME OSTEO Assessing the efficacy of the Biome Lift™ Analysing the influence of probiotic use on Examining the effect of 12-month absenteeism and immune hea
Slide 15: Distribution Network and Sales Model
15 04 PAGE Practitioner-only probiotics Distribution Network and Sales Model ACTIVATEDPROBIOTICS.COM.AU Commercial in confidence PG.15
Slide 16: Australian Distribution Network
Australian Distribution Network ● Biome Australia currently has over 3000 distribution points, between community pharmacies and independent health practitioners ● Strategic partnerships with Terry White Chemmart resigned for FY23 ● Distribution agreement signed with Priceline Pharmacy in Q4 FY22. Ph
Slide 17: Training and Education Driven Sales Model
Training and Education Driven Sales Model Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • The Biome sales team is a mix of health qualified practitioner education consultants and territory managers • Practitioner education consultants undertake
Slide 18: Health Advertising
Health Advertising Activated Probiotics - Point of purchase windows and billboards
Slide 19: Health Practitioner & Patient Feedback
Health Practitioner & Patient Feedback Biome Lift Probiotic Biome IBS Probiotic “My patient has been on a prescription sertraline “I have suffered with IBS for a few years and nothing has (anti-depressant) for a number of years to manage his mental helped and have found myself in very uncomfortable &
Slide 20: Health Practitioner & Patient Feedback
Health Practitioner & Patient Feedback Biome Breathe Probiotic Biome Acne Probiotic “As a children's health naturopath Biome Breathe has been an “I just wanted to email to let you know how much I love the invaluable addition to my tool kit! I've been using Biome new Biome Acne product! I have used i
Slide 21: Growth Strategy
05 Growth Strategy Commercial in confidence PG.21 ACTIVATEDPROBIOTICS.COM.AU Practitioner-only probiotics PAGE 21
Slide 22: Addressable Market & Growth Strategy
Addressable Market & Growth Strategy PG.22
Slide 23: Short term growth strategies
Short term growth strategies 1 - 3 YEARS Increase average account Increase distribution into new sell-through of Activated Probiotics pharmacy and health practitioners across all existing distribution points $+ Biome’s top three distribution outlets are averaging $100k+ per year of Activated 25 50%
Slide 24: Short term growth strategies
Short term growth strategies 1 - 3 YEARS Develop the adjunct medication and Continue measured expansion into co-prescribing market the UK / EU market $2.8B Biome has a unique opportunity in the suitability of Activated Probiotics’ products to be recommended alongside various medications by pharmacis
Slide 25: Long term growth strategies 5+ years
Long term growth strategies 5+ YEARS Drive profitability to deliver exceptional Explore distribution opportunities in shareholder returns including dividends new markets across Europe, North America and Asia-Pacific Further develop Biome’s adjunct medication market’ within community Explore further
Slide 26: FY22 Financial Highlights
06 Highlights FY22 Financial Commercial in confidence PG.26 ACTIVATEDPROBIOTICS.COM.AU Practitioner-only probiotics PAGE 26
Slide 27: FY22 - Financial Highlights
FY22 - Financial Highlights FY21 FY22 Comments $’000 $’000 Sales 2,318 4,122 +78% Gross Profit 1,179 2,387 +102% Gross Margin % 51% 58% +7% (abs) R&D rebate & Export Market Development Grant (EMDG) 267 270 +1% Government JobKeeper support 124 nil -100% Sales and marketing expenses (3,390) (3,533) +4
Slide 28: Biome Australia Limited FY22 Presentation
Contact details: Blair Norfolk, CEO e: blair@activated.co Douglas Loh, CFO e: douglas@activated.co Websites: biomeaustralia.com activatedprobiotics.com.au activatednutrients.com activatedxperformance.com.au Biome Australia Limited FY22 Presentation Commercial in confidence PG.28
Biome Australia — Investor Presentation (October 2022) on 6ix